McKinsey under criminal investigation for role in opioid epidemic
In a riveting twist of events, McKinsey & Co finds itself at the centre of a criminal investigation in the United States, accused of exacerbating the opioid crisis. Federal prosecutors are honing in on the firm's alleged pivotal role in advising Purdue Pharma and other drugmakers on marketing strategies that fueled addiction and fatal overdoses. With potential charges looming, this inquiry unveils the enduring repercussions of McKinsey's past dealings, raising questions about accountability and justice in the pharmaceutical landscape.
Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.
SOURCE: REUTERS
By Mike Spector, Nate Raymond and Chris Prentice
NEW YORK, April 24 (Reuters) – McKinsey & Co is under criminal investigation in the United States over allegations that the consulting firm played a key role in fueling the opioid epidemic, with federal prosecutors homing in on its work advising OxyContin maker Purdue Pharma and other drugmakers, three people familiar with the matter said.
___STEADY_PAYWALL___